Van der Galien HT, Kooistra HA, Veeger NJGM, et al. Outcome of a 10-year population-based cohort of diffuse large B-cell lymphoma patients in the first-line, refractory and relapsed setting: ‘real world’ data identify subgroups in need of new therapies. EHA 2018; poster PF287.
Overleving oudere CML-patiënt blijft achter, ook in TKI-tijdperk
jul 2020 | Leukemie, Ouderen